|
ZNHIT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56500000000537E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.438800E-04 |
| Normal-vs-Stage2 |
1.7606599999942E-05 |
| Normal-vs-Stage3 |
5.86769999999515E-05 |
| Normal-vs-Stage4 |
1.977350E-03 |
| Stage1-vs-Stage2 |
1.921680E-02 |
| Stage1-vs-Stage3 |
3.214600E-01 |
| Stage1-vs-Stage4 |
9.322000E-01 |
| Stage2-vs-Stage3 |
1.308190E-01 |
| Stage2-vs-Stage4 |
7.181600E-02 |
| Stage3-vs-Stage4 |
5.172600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.199490E-04 |
| Normal-vs-AfricanAmerican |
7.240200E-03 |
| Normal-vs-Asian |
1.078220E-03 |
| Caucasian-vs-AfricanAmerican |
8.238800E-01 |
| Caucasian-vs-Asian |
9.281200E-01 |
| AfricanAmerican-vs-Asian |
8.871400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53669999952899E-07 |
| Normal-vs-Female |
2.783700E-04 |
| Male-vs-Female |
7.753500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.877220E-03 |
| Normal-vs-Age(41-60Yrs) |
2.19169999999824E-05 |
| Normal-vs-Age(61-80Yrs) |
2.27859999999414E-05 |
| Normal-vs-Age(81-100Yrs) |
7.684200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.917000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.368780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.330400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.566200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.369800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.108000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.436790E-01 |
| Classical-VS-Follicular |
8.140900E-03 |
| Classical-VS-Other |
1.833040E-01 |
| Classical-VS-Normal |
4.238800E-04 |
| Tall-VS-Follicular |
1.580980E-03 |
| Tall-VS-Other |
1.602080E-02 |
| Tall-VS-Normal |
7.829900E-02 |
| Follicular-VS-Other |
6.333400E-01 |
| Follicular-VS-Normal |
2.31170000031256E-07 |
| Other-VS-Normal |
2.782100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78230000003055E-06 |
| Normal-vs-N1 |
2.585500E-04 |
| N0-vs-N1 |
7.784800E-01 |
|
|
